← Back to Search

Subjects with spinal epidural abscess with a history of drug abuse for Spinal Epidural Abscess (SEA Trial)

N/A
Recruiting
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* All patient with ICD codes for pyogenic vertebral osteomyelitis, discitis, and spinal epidural abscess will be reviewed for inclusion.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical, pathological, radiological, and socioeconomic data of patients diagnosed with a spinal infection with or without a history of drug abuse over this study period. All patients' charts will be prospectively reviewed starting at the time of presentation for a period of 1 year.

Eligible Conditions
  • Spinal Epidural Abscess

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation between employment status and infection reoccurrence.
Correlation between income and infection reoccurrence.
Correlation between insurer and infection reoccurrence.
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Subjects with spinal epidural abscess with no history of drug abuseExperimental Treatment1 Intervention
Group II: Subjects with spinal epidural abscess with a history of drug abuseExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of KentuckyLead Sponsor
189 Previous Clinical Trials
220,484 Total Patients Enrolled
~14 spots leftby Dec 2024